MoneyWorks4Me

Advanced Enzyme Technologies submits unaudited financial results

12 Feb 2021 Evaluate

Advanced Enzyme Technologies has informed that it enclosed the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine-months ended December 31, 2020 along with the Limited Review report issued by BSR & Co. LLP, Statutory Auditors of the Company. The aforesaid financial results along with Limited review report are also being uploaded on the website of the Company, www.advancedenzymes.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.95
Dr. Reddys Labs. 1239.00
Cipla 1329.90
Lupin 1928.00
Zydus Lifesciences 1135.00
View more..